Unlocking the potential of non-coding RNAs in cancer research and therapy-Reference-Cited by-同舟云学术

Unlocking the potential of non-coding RNAs in cancer research and therapy

Published:2023-09 Issue: Volume:35 Page:101730
ISSN:1936-5233
Container-title:Translational Oncology
language:en
Short-container-title:Translational Oncology

Author:

Uppaluri Kalyan Ram^ORCID,Challa Hima J,Gaur Ashish,Jain Rajul,Krishna Vardhani K,Geddam Anusha,Natya K,Aswini K,Palasamudram Kalyani,K Sri Manjari^ORCID

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference113 articles.

1. Progress in delivery of siRNA-based therapeutics employing nano-vehicles for treatment of prostate cancer;Ashrafizadeh;Bioengineering,2020

2. MicroRNAs: target recognition and regulatory functions;Bartel;Cell,2009

3. Overview upon miR-21 in lung cancer: focus on NSCLC;Bica-Pop;Cell. Mol. Life Sci.,2018

4. Bierhoff, H., 2018. Analysis of lncRNA-protein interactions by RNA-protein pull-down assays and RNA immunoprecipitation (RIP). pp. 241–250. doi:10.1007/978-1-4939-7371-2_17.

5. Integrative annotation of human large intergenic noncoding RNAs reveals global properties and specific subclasses;Cabili;Genes Dev.,2011

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Decoding PTEN regulation in clear cell renal cell carcinoma: Pathway for biomarker discovery and therapeutic insights;Biochimica et Biophysica Acta (BBA) - Reviews on Cancer;2024-09

2. Editorial: Role of non-coding RNAs (emphasis on the emerging role of circular RNAs) in cancer. Application potential for molecular diagnostics and therapeutics of cancer;Frontiers in Genetics;2024-07-25

3. Editorial: Non-coding RNAs as emerging players in the development, diagnosis, and treatment of cancer;Frontiers in Molecular Biosciences;2024-07-23

4. Personalizing Therapy Outcomes through Mitogen-Activated Protein Kinase Pathway Inhibition in Non-Small Cell Lung Cancer;Biomedicines;2024-07-05

5. Диагностический потенциал регуляторных не кодирующих белок РНК при хроническом лимфоцитарном лейкозе;Clinical Oncohematology;2024-04-01